510(k) Report

FDA product code · Radiology

Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer

POKClass II21 CFR 892.2060510(k) required24 decisions since 20170 recalls

24 FDA decisions since 2017. 510(k) reviews decided 2021–2025 took a median of 154 days (half between 118 and 176). No recall names this code. The most-cited predicate is DEN170022, named by 4 later devices.

Assist users in characterizing lesions identified on acquired medical images

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, radiology panel

Twenty years of POK at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · POK

5in 2025

2017: 12019: 12020: 22021: 22022: 12023: 12024: 62025: 52026 (partial year): 5
2007high 6 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · POK

119in 2025

2024: 161 days median2025: 119 days median2026 (partial year): 155 days median
2007high 161 (2024) · low 119 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · POK

No recall names POK since 2007.

Adverse event reports per year · POK

1in 2021

2021: 1
2007high 1 (2021) · low 0 (2007)2025

MAUDE reports naming product code POK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20180—00
20191—00
20202—00
20212—01
20221—00
20231—00
2024616100
2025511900
202651550—
FIG. 1 — POK by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in POK? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report